Shuzheng Lyu

Shuzheng Lyu


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2021 in Angiology
Verified
Journal Article
Closed access
PDF file
KZKuo Zhou
Kuo Zhou
ZQZheng Qin
Zheng Qin
JTJinfan Tian
Jinfan Tian
KCKongyong Cui
Kongyong Cui
YYYunfeng Yan
Yunfeng Yan
SLShuzheng Lyu
Shuzheng Lyu
We evaluated the predictive power of the atherogenic index of plasma (AIP) for coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM). A total of 3278 patients who underwent coronary angiography were consecutively enrolled, including 2052 patients with CAD and 1226 patients with T2DM but without CAD. Patients in the CAD group had higher levels of triglyceride (TG), total cholesterol, low-density lipoprotein cholesterol, AIP and a lower level of high-density lipoprotein cholesterol (HDL-C). In correlation analyses, AIP correlated positively with body mass index, log (homeostasis model assessment of insulin resistance), TG, remnant lipoprotein cholesterol, non–HDL-C, but negatively with age and HDL-C. Multivariate logistic regression analyses demonstrated that AIP was an independent risk factor for CAD in diabetic patients and was validated by multiple models. Furthermore, the ORs for CAD risk were raised with increasing AIP quartiles; ORs of AIP quartiles Q2–Q4 compared with Q1 were 1.56, 1.70, and 2.22, respectively (Ps < .001), which suggested AIP was the lipid parameter that most strongly associated with incident CAD. In conclusion, AIP is a powerful and reliable biomarker for predicting CAD risk beyond individual lipid profiles in patients with T2DM.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JTJinfan Tian
Jinfan Tian
YZYingke Zhao
Yingke Zhao
YLYanfei Liu
Yanfei Liu
YLYue Liu
Yue Liu
KCKeji Chen
Keji Chen
SLShuzheng Lyu
Shuzheng Lyu
Diabetic cardiomyopathy is one of the major complications among patients with diabetes mellitus. Diabetic cardiomyopathy (DCM) is featured by left ventricular hypertrophy, myocardial fibrosis, and damaged left ventricular systolic and diastolic functions. The pathophysiological mechanisms include metabolic‐altered substrate metabolism, dysfunction of microvascular, renin‐angiotensin‐aldosterone system (RAAS) activation, oxidative stress, cardiomyocyte apoptosis, mitochondrial dysfunction, and impaired Ca2+ handling. An array of molecules and signaling pathways such as p38 mitogen‐activated protein kinase (p38 MAPK), c‐Jun N‐terminal kinase (JNK), and extracellular‐regulated protein kinases (ERK) take roles in the pathogenesis of DCM. Currently, there was no remarkable effect in the treatment of DCM with application of single Western medicine. The myocardial protection actions of herbs have been gearing much attention. We present a review of the progress research of herbal medicine as a potential therapy for diabetic cardiomyopathy and the underlying mechanisms.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JTJinfan Tian
Jinfan Tian
YLYanfei Liu
Yanfei Liu
YLYue Liu
Yue Liu
KCKeji Chen
Keji Chen
SLShuzheng Lyu
Shuzheng Lyu
Diabetes was induced in high‐fat diet‐fed ApoE−/− mice via administration of low‐dose streptozotocin (STZ) for five days. Mice were then treated with GBE (200 or 400 mg/kg) by gastric gavage daily for 12 weeks. Mice in the untreated diabetic group received saline instead, and nondiabetic C57BL/6J mice served as controls. Collagen І and ІІІ mRNA expression was measured by real‐time PCR. TNF‐α, IL‐1β mRNA levels, and NF‐κB expression were determined to analyze intramyocardial inflammation. Hallmarks of endoplasmic reticulum stress‐ (ERS‐) related apoptosis pathways, including phosphorylated c‐Jun N‐terminal kinase (p‐JNK), C/EBP homologous protein (CHOP), caspase‐12, and cleaved caspase‐3, were analyzed by Western blotting. Diabetic ApoE−/− myocardial injury was associated with increased cardiomyocyte apoptosis (increased expression of p‐JNK, CHOP, caspase‐12, and cleaved caspase‐3), interstitial fibrosis (increased mRNA levels of collagen І and ІІІ), and inflammation (increased mRNA levels of TNF‐α and IL‐1β, and NF‐κB expression). GBE at 200 and 400 mg/kg/day significantly attenuated cardiomyocyte apoptosis, collagen deposition, and inflammation in diabetic mice via inhibition of the p‐JNK, CHOP, and caspase‐12 pathways. Serum levels of the proinflammatory cytokines (IL‐6, IL‐1β, and TNF‐α), blood glucose, and lipid profiles were also regulated by GBE treatment. GBE might be beneficial in the treatment of diabetic myocardial injury.

16 April 2018 in Angiology
Verified
Journal Article
Closed access
KCKongyong Cui
Kongyong Cui
SLShuzheng Lyu
Shuzheng Lyu
XSXiantao Song
Xiantao Song
FYFei Yuan
Fei Yuan
FXFeng Xu
Feng Xu
JTJinfan Tian
Jinfan Tian
The impact of coronary collaterals on the prognosis in patients with acute ST-segment elevation myocardial infarction (STEMI) in the era of coronary revascularization remains controversial. The purpose of this meta-analysis was to investigate the effect of coronary collateral on clinical outcomes, especially mortality (≥6 months), in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI. Eligible observational studies were selected by searching PubMed, EMBASE, and Cochrane Library up to August 9, 2017. Overall, 14 observational studies involving 10 411 patients were included. Coronary collaterals were found to reduce the risk of long-term mortality (≥6 months; risk ratio [RR]: 0.65, 95% confidence interval [CI]: 0.55-0.76) as well as in-hospital plus 30-day mortality (RR: 0.61, 95% CI: 0.47-0.78) in patients undergoing PCI for STEMI. In addition, pooling the risk-adjusted or propensity-matched data showed a significant reduction in long-term mortality (RR: 0.68, 95% CI: 0.49-0.95) and in-hospital plus 30-day mortality (RR: 0.27, 95% CI: 0.13-0.55) in patients with collateral circulation. However, no significant difference was found in the risk of recurrent myocardial infarction and target vessel revascularization between the 2 groups. Therefore, it was found that coronary collaterals have a beneficial effect on long-term survival (≥6 months) as well as in-hospital plus 30-day survival in patients undergoing primary PCI for STEMI.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JTJinfan Tian
Jinfan Tian
YLYanfei Liu
Yanfei Liu
YLYue Liu
Yue Liu
KCKeji Chen
Keji Chen
SLShuzheng Lyu
Shuzheng Lyu
An increasing number of patients diagnosed with diabetes mellitus eventually develop severe coronary atherosclerosis disease. Both type 1 and type 2 diabetes mellitus increase the risk of cardiovascular disease associated with atherosclerosis. The cellular and molecular mechanisms affecting the incidence of diabetic atherosclerosis are still unclear, as are appropriate strategies for the prevention and treatment of diabetic atherosclerosis. In this review, we discuss progress in the study of herbs as potential therapeutic agents for diabetic atherosclerosis.

1 November 2018 in The American Journal of Cardiology
Verified
Journal Article
Closed access
KCKongyong Cui
Kongyong Cui
DZDongfeng Zhang
Dongfeng Zhang
SLShuzheng Lyu
Shuzheng Lyu
XSXiantao Song
Xiantao Song
FYFei Yuan
Fei Yuan
MZMin Zhang
Min Zhang